210 related articles for article (PubMed ID: 37577269)
1. The Efficacy of Carvedilol in Comparison to Propranolol in Reducing the Hepatic Venous Pressure Gradient and Decreasing the Risk of Variceal Bleeding in Adult Cirrhotic Patients: A Systematic Review.
Dardari L; Taha M; Dahat P; Toriola S; Satnarine T; Zohara Z; Adelekun A; Seffah KD; Salib K; Arcia Franchini AP
Cureus; 2023 Aug; 15(8):e43253. PubMed ID: 37577269
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis.
Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Balcar L; Hofer B; Pfisterer N; Schwarz M; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2318-2326.e7. PubMed ID: 35842118
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT.
Gupta V; Rawat R; Shalimar ; Saraya A
Hepatol Int; 2017 Mar; 11(2):181-187. PubMed ID: 27624505
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.
Kirnake V; Arora A; Gupta V; Sharma P; Singla V; Bansal N; Goyal M; Chawlani R; Kumar A
J Clin Exp Hepatol; 2016 Sep; 6(3):175-185. PubMed ID: 27746613
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic prevention of variceal bleeding and rebleeding.
Baiges A; Hernández-Gea V; Bosch J
Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of carvedilol for the treatment of portal hypertension.
Hemstreet BA
Pharmacotherapy; 2004 Jan; 24(1):94-104. PubMed ID: 14740791
[TBL] [Abstract][Full Text] [Related]
8. Use of portal pressure studies in the management of variceal haemorrhage.
Addley J; Tham TC; Cash WJ
World J Gastrointest Endosc; 2012 Jul; 4(7):281-9. PubMed ID: 22816007
[TBL] [Abstract][Full Text] [Related]
9. Long-term Outcomes with Carvedilol versus Propranolol in Patients with Index Variceal Bleed: 6-year Follow-up Study.
Sharma S; Agarwal S; Gunjan D; Kaushal K; Anand A; Mohta S; Shalimar ; Saraya A
J Clin Exp Hepatol; 2021; 11(3):343-353. PubMed ID: 33994717
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis.
Li T; Ke W; Sun P; Chen X; Belgaumkar A; Huang Y; Xian W; Li J; Zheng Q
BMJ Open; 2016 May; 6(5):e010902. PubMed ID: 27147389
[TBL] [Abstract][Full Text] [Related]
11. Complications of cirrhosis. I. Portal hypertension.
Bosch J; García-Pagán JC
J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
[TBL] [Abstract][Full Text] [Related]
12. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
13. Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension.
Wei ZG; Wei FX; Shao ZW; Su GH; Qi XP; Zhang YC
Ther Clin Risk Manag; 2019; 15():45-57. PubMed ID: 30636878
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Zacharias AP; Jeyaraj R; Hobolth L; Bendtsen F; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011510. PubMed ID: 30372514
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of carvedilol versus propranolol versus variceal band ligation for primary prevention of variceal bleeding.
Abd ElRahim AY; Fouad R; Khairy M; Elsharkawy A; Fathalah W; Khatamish H; Khorshid O; Moussa M; Seyam M
Hepatol Int; 2018 Jan; 12(1):75-82. PubMed ID: 29185106
[TBL] [Abstract][Full Text] [Related]
16. A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.
Kim SG; Kim TY; Sohn JH; Um SH; Seo YS; Baik SK; Kim MY; Jang JY; Jeong SW; Lee B; Kim YS; Suk KT; Kim DJ
Am J Gastroenterol; 2016 Nov; 111(11):1582-1590. PubMed ID: 27575713
[TBL] [Abstract][Full Text] [Related]
17. Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial.
Sarin SK; Mishra SR; Sharma P; Sharma BC; Kumar A
Hepatol Int; 2013 Mar; 7(1):248-56. PubMed ID: 26201639
[TBL] [Abstract][Full Text] [Related]
18. Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG.
Zhang M; Wang G; Zhao L; Wu Z; Zhang W; Zhang C
Scand J Gastroenterol; 2016 Dec; 51(12):1502-1506. PubMed ID: 27379704
[TBL] [Abstract][Full Text] [Related]
19. 5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial.
Vukotic R; Di Donato R; Roncarati G; Simoni P; Renzulli M; Gitto S; Schepis F; Villa E; Berzigotti A; Bosch J; Andreone P
J Hepatol; 2023 Oct; 79(4):977-988. PubMed ID: 37482222
[TBL] [Abstract][Full Text] [Related]
20. Increase in Free Hepatic Venous Pressure Response to Beta-Blockers Predicts Variceal Bleeding in Cirrhotic Patients.
Guo H; Xiao J; Wang Y; Zhang M; Zhuge Y; Zhang F
Biomed Res Int; 2021; 2021():5587566. PubMed ID: 33997022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
